{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:21:09Z","timestamp":1793409669916,"version":"4.5.0"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Major histocompatibility complex (MHC) class II deficiency is a rare, life-threatening primary immunodeficiency that presents in early infancy with a SCID phenotype. However, emerging data indicate substantial clinical and immunological heterogeneity, including atypical presentations and neurological involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively evaluated the clinical, immunological, genetic, and treatment-related characteristics and outcomes of 22 patients from 19 unrelated families diagnosed with MHC class II deficiency at a single referral center (2000\u20132019). Ten patients underwent HSCT at our center; transplant-related outcomes were evaluated, and long-term follow-up data were available for the six surviving patients through 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age at symptom onset and diagnosis was 9 and 12 months, respectively. Pneumonia, chronic diarrhea, and failure to thrive were the most common presenting features; neurological manifestations and developmental delay were observed in a subset of patients. Two patients showed residual HLA-DR expression and survived with a milder clinical course. CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell lymphopenia and humoral dysfunction were consistent, while total lymphocyte counts were variable. RTE levels were mildly to moderately reduced in all tested patients, suggesting impaired thymic output. Severe viral infections were frequent and could be rapidly fatal. Fourteen patients required PICU admission, associated with high mortality. Genetic analysis (n:15) identified homozygous pathogenic variants in\n                      <jats:italic>RFXANK<\/jats:italic>\n                      (n=5),\n                      <jats:italic>RFXAP<\/jats:italic>\n                      (n=4),\n                      <jats:italic>RFX5<\/jats:italic>\n                      (n=3), and\n                      <jats:italic>CIITA<\/jats:italic>\n                      (n=3). Ten patients underwent HSCT, with superior survival compared to non-transplanted patients (60% vs. 18%). Among transplanted patients, survival appeared higher following RTC than MAC (75% vs. 50%). Post-transplant mortality was observed in association with severe pre-transplant disease, delayed diagnosis, graft failure, and infectious complications. At \u226510 years post-HSCT, all survivors were IVIG-independent; CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cell recovery was higher after MAC than RTC, while T-cell chimerism remained mixed in both groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MHC class II deficiency is a SCID-like pediatric immunological emergency that is fatal without HSCT in most patients. Early diagnosis is critical, as initial infections may be rapidly progressive. HSCT provides durable engraftment and sustained clinical stability in long-term survivors. Incorporating HLA-DR expression analysis into first-line immunological screening, even in the absence of profound lymphopenia, may facilitate earlier diagnosis, prompt HSCT referral, and improve survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1811502","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:36:57Z","timestamp":1776832617000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical, immunological, treatment characteristics, and outcomes in 22 patients with major histocompatibility complex class II deficiency"],"prefix":"10.3389","volume":"17","author":[{"given":"Sule","family":"Haskologlu","sequence":"first","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, and Hematopoietic Stem Cell Transplantation Unit, Faculty of Medicine, Ankara University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Aytekin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Allergy and Immunology, Dr. Sami Ulus Children\u2019s Health and Diseases Training and Research Hospital","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candan","family":"Islamoglu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, and Hematopoietic Stem Cell Transplantation Unit, Faculty of Medicine, Ankara University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevgi","family":"Kostel Bal","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, G\u00fclhane Training and Research Hospital","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kubra","family":"Bask\u0131n","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, Faculty of Medicine, Gazi University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran","family":"Erman","sequence":"additional","affiliation":[{"name":"Can Sucak Research Laboratory for Translational Immunology, Hacettepe University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tan\u0131l","family":"Kendirli","sequence":"additional","affiliation":[{"name":"Department of Pediatric \u0130ntensive Care Unit, Faculty of Medicine, Ankara University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Ceylaner","sequence":"additional","affiliation":[{"name":"Intergen Genetics and Rare Diseases Diagnosis Research & Application Center","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Dogu","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, and Hematopoietic Stem Cell Transplantation Unit, Faculty of Medicine, Ankara University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Ikinciogullari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Immunology and Allergy, and Hematopoietic Stem Cell Transplantation Unit, Faculty of Medicine, Ankara University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.331","article-title":"The bare lymphocyte syndrome and the regulation of MHC expression","volume":"19","author":"Reith","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200111000-00006","article-title":"MHC class II deficiency: a disease of gene regulation","volume":"80","author":"Villard","year":"2001","journal-title":"Med (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/s0022-3476(78)80598-8","article-title":"Combined immunodeficiency disease associated with absence of cell-surface HLA-A and -B antigens","volume":"93","author":"Touraine","year":"1978","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(05)80388-9","article-title":"Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome","volume":"123","author":"Klein","year":"1993","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0268-960x(96)90008-9","article-title":"Major histocompatibility complex class II deficiency: a clinical review","volume":"10","author":"Elhasid","year":"1996","journal-title":"Blood Rev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.01.002","article-title":"Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency","volume":"16","author":"Al-Mousa","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-352716","article-title":"Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patients","volume":"118","author":"Ouederni","year":"2011","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-8-14","article-title":"Clinical, immunological and genetic features in eleven Algerian patients with major histocompatibility complex class II expression deficiency","volume":"8","author":"Djidjik","year":"2012","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9863-8","article-title":"Clinical, immunological and genetic findings of a large Tunisian series of major histocompatibility complex class II deficiency patients","volume":"33","author":"Ben-Mustapha","year":"2013","journal-title":"J ClinImmunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9831-8","article-title":"Major histocompatibility complex class II deficiency in Kuwait: clinical manifestations, immunological findings and molecular profile","volume":"33","author":"Al-Herz","year":"2013","journal-title":"J ClinImmunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1402038","article-title":"Flow cytometry-based diagnostic approach for inborn errors of immunity: experience from Algeria","volume":"15","author":"Tahiat","year":"2024","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1179-6","article-title":"The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan population","volume":"169","author":"Naamane","year":"2010","journal-title":"Eur J Pediatr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.06.001","article-title":"MHC class I and II deficiencies","volume":"134","author":"Hanna","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01562-z","article-title":"Clinical, immunological, and genetic findings in Iranian patients with MHC-II deficiency: confirmation of c.162delG RFXANK founder mutation in the Iranian population","volume":"43","author":"Mousavi Khorshidi","year":"2023","journal-title":"J ClinImmunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2017.04.006","article-title":"MHC class II deficiency: report of a novel mutation and special review","volume":"46","author":"Farrokhi","year":"2018","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00188","article-title":"Clinical, immunological, and molecular findings in five patients with major histocompatibility complex class II deficiency from India","volume":"9","author":"Aluri","year":"2018","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.07.046","article-title":"MHC-II deficiency among Egyptians: novel mutations and unique phenotypes","volume":"7","author":"El Hawary","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1016\/j.jaip.2024.06.046","article-title":"MHC class II deficiency: clinical, immunological, and genetic insights in a large multicenter cohort","volume":"12","author":"Gulec Koksal","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13335","article-title":"A large single-center cohort of bare lymphocyte syndrome: immunological and genetic features in Turkey","volume":"99","author":"\u00dcnsal","year":"2024","journal-title":"Scand J Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.3.1787","article-title":"Mutation in the class II trans-activator leading to a mild immunodeficiency","volume":"167","author":"Wiszniewski","year":"2001","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1155\/crii\/8570051","article-title":"Major histocompatibility complex class II deficiency beyond infancy","volume":"2025","author":"Kattra","year":"2025","journal-title":"Case Rep Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-024-01674-0","article-title":"Novel presentation of major histocompatibility complex class II deficiency with hemophagocytic lymphohistiocytosis","volume":"44","author":"Alroqi","year":"2024","journal-title":"J ClinImmunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae102","article-title":"Early onset polyarthritis: an unusual presentation of MHC class II deficiency","volume":"63","author":"Sil","year":"2024","journal-title":"Rheumatol (Oxford)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1269396","article-title":"Case report: a late and isolated presentation of meningoencephalomyelitis uncovers a novel pathogenic variant in the CIITA gene","volume":"11","author":"Alroqi","year":"2023","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v85.2.580.bloodjournal852580","article-title":"Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients","volume":"85","author":"Klein","year":"1995","journal-title":"Blood"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/adc.83.4.356","article-title":"Clinical course of patients with major histocompatibility complex class II deficiency","volume":"83","author":"Saleem","year":"2000","journal-title":"Arch Dis Child"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2010.01292.x","article-title":"MHC class II deficiency cured by unrelated mismatched umbilical cord blood transplantation: case report and review of 68 cases in the literature","volume":"15","author":"Siepermann","year":"2011","journal-title":"Pediatr Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06213.x","article-title":"Human leucocyte antigen-identical haematopoietic stem cell transplantation in major histocompatiblity complex class II immunodeficiency: reduced survival correlates with an increased incidence of acute graft-versus-host disease and pre-existing viral infections","volume":"134","author":"Renella","year":"2006","journal-title":"Br J Haematol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00516","article-title":"Hematopoietic cell transplantation for MHC class II deficiency","volume":"7","author":"Lum","year":"2019","journal-title":"Front Pediatr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002690","article-title":"Improved transplant survival and long-term disease outcome in children with MHC class II deficiency","volume":"135","author":"Lum","year":"2020","journal-title":"Blood"},{"key":"B31","article-title":"Sa\u011fl\u0131kl\u0131 T\u00fcrk \u00e7ocuklar\u0131 ve eri\u015fkinlerde t\u00fcrbimetrik y\u00f6ntemle bak\u0131lan serum imm\u00fcnglob\u00fclin d\u00fczeyleri","volume":"39","author":"Tezcan","year":"1996","journal-title":"\u00c7ocuk Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131 Dergisi"},{"key":"B32","article-title":"Peripheral blood lymphocyte subsets in healthy Turkish children","volume":"46","author":"Ikinciogullari","year":"2004","journal-title":"Turk J Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.24953\/turkjped.2021.5190","article-title":"A. Evaluation of thymopoiesis in healthy Turkish children aged 0\u20136 years","volume":"65","author":"Kavgac\u0131","year":"2023","journal-title":"Turk J Pediatr"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The european society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1006\/mthe.2002.0804","article-title":"Direct genetic correction as a new method for diagnosis and molecular characterization of MHC class II deficiency","volume":"6","author":"Matheux","year":"2002","journal-title":"Mol Ther"},{"key":"B36","unstructured":"EBMT\/ESID Guidelines for Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies. Inborn Errors Working Party\n          \n          \n          \n          2017"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2021.04.007","article-title":"Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cellular Therapy","volume":"27","author":"Kharfan-Dabaja","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01062-y","article-title":"Single-center study of 72 patients with severe combined immunodeficiency: clinical and laboratory features and outcomes","volume":"41","author":"Bayram","year":"2021","journal-title":"J ClinImmunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669943","article-title":"Thymic epithelial cell alterations and defective thymopoiesis lead to central and peripheral tolerance perturbation in MHCII deficiency","volume":"12","author":"Ferrua","year":"2021","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.12932\/AP-020720-0898","article-title":"Novel variants in CIITA caused type II bare lymphocyte syndrome: a case report","volume":"42","author":"Zhang","year":"2024","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"594","DOI":"10.18502\/ijaai.v17i6.624","article-title":"MHC class II deficiency with normal CD4+ T cell counts: a case report","volume":"17","author":"Abolnezhadian","year":"2018","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-023-04750-2","article-title":"Major histocompatibility complex (MHC) class II deficiency- a case of primary immunodeficiency disorder","volume":"91","author":"Radhika","year":"2024","journal-title":"Indian J Pediatr"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.10.040","article-title":"Thymic function in MHC class II-deficient patients","volume":"131","author":"Lev","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.019","article-title":"Newborn screening for severe combined immunodeficiency does not identify bare lymphocyte syndrome","volume":"131","author":"Kuo","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-9019-2","article-title":"MHC II deficient infant identified by newborn screening program for SCID","volume":"66","author":"Marcus","year":"2018","journal-title":"Immunol Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-020-09141-9","article-title":"A novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency: a case report","volume":"68","author":"Abolnezhadian","year":"2020","journal-title":"Immunol Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12026-025-09627-4","article-title":"A patient with RFX5 variant causing an expression defect in both HLA ABC and HLA DR","volume":"73","author":"Goktas","year":"2025","journal-title":"Immunol Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1811502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:37:04Z","timestamp":1776832624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1811502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2026.1811502"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1811502","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1811502"}}